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OBJECTIVE: Dengue is a worldwide public health problem with approximately 50 million cases reported
annually. The World Health Organization proposed a revised classification system in 2008 to more effectively
identify the patients who are at increased risk of complications from dengue. Few studies have validated this
new classification system in clinical practice. We conducted a cross-sectional study of patients hospitalized for
dengue in Dourados, Mato Grosso do Sul, Brazil, to evaluate the capacity of the two classification systems for
detecting severe cases of dengue.
MATERIALS AND METHODS: We conducted a cross-sectional study of survey data from the medical records of
patients admitted to the University Hospital of the Federal University of Grande Dourados under clinical
suspicion of dengue during an epidemic from September 2009 to April 2010.
RESULTS: The distribution of patients according to the traditional classification system was as follows: dengue
fever, 150/181 (82.9%); dengue hemorrhagic fever, 27/181 (14.9%); and dengue hemorrhagic shock, 4/181
(2.2%). Using the revised classification system, the distribution was as follows: dengue without warning signs,
45/181 (24.3%); dengue with warning signs, 107/181 (59.1%); and severe dengue, 29/181 (15.6%). Of the 150
patients classified as having dengue fever, 105 (70%) were reclassified as having dengue with warning signs or
severe dengue.
CONCLUSION: These data demonstrate that the revised classification system has greater discriminatory power
for detecting patients at risk of progression to severe disease and those needing hospitalization.
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& INTRODUCTION
Dengue is an important arthropod-borne viral disease
found worldwide. Dengue is caused by four serotypes of the
genus Flavivirus (DENV-1, DENV-2, DENV-3, and DENV-4)
and is transmitted via the bite of the Aedes aegypti mosquito,
an urban vector that has adapted to human dwellings (1-7).
The worldwide incidence of dengue has increased over
the past three decades. There are approximately 50 million
symptomatic infections per year, and approximately two
million cases require hospitalization, indicating that dengue
is a serious global public health concern (8-11).
There is no vaccine or specific treatment for preventing
the natural progression of the disease, and it is important
that physicians have the appropriate tools to diagnose
severe forms of dengue rapidly and accurately. This
diagnosis requires a clinical classification system that
provides simple and quick detection of patients who may
develop more severe disease. It is especially important to
detect plasma leakage, which is treated with intravenous
rehydration, to reduce the mortality of dengue (8,10,12).
The 1997 World Health Organization (WHO) classifica-
tion subdivides dengue into dengue fever (DF), dengue
hemorrhagic fever (DHF), and dengue shock syndrome
(DSS). The criteria for classifying a patient as having DHF
are very rigid; the patient must exhibit four criteria: fever,
hemorrhagic manifestations, thrombocytopenia, and evi-
dence of third-space fluid loss (serous effusions, hemocon-
centration, or hypoproteinemia) (4,6,12).
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Several limitations to the practical applicability of these
criteria have been noted, particularly in the evaluation of
severe cases. Many patients who develop a severe clinical
presentation do not meet the criteria for DHF and are
ultimately classified as having dengue fever. In 2008, the
WHO proposed a new classification system, based on a
multicenter study in Asian and Latin American countries, that
provided a list of clinical signs suggestive of a severe disease
outcome (warning signs). This system classified dengue into
dengue without warning signs (DWWS), dengue with
warning signs (DWS), and severe dengue (SD) (4,6,12,13).
The WHO dengue classification of 1997 aims to stratify
dengue patients according to the pathophysiological level of
disease progression, particularly with respect to the
occurrence of plasma leakage. The WHO dengue classifica-
tion of 2008 uses clinical signs and symptoms to stratify
dengue patients according to disease severity (4,6,12,13).
Based on this perspective, a cross-sectional survey was
conducted to evaluate the ability of the two classification
systems to detect severe cases of dengue based on the
medical records of dengue patients who were admitted to
the University Hospital of the Federal University of Grande
Dourados during the dengue epidemic in the summers of
2009-2010. This study is the first in Brazil to evaluate the
revised WHO classification criteria.
& MATERIAL AND METHODS
Data were collected through patient notification obtained
from the National Notifiable Diseases Information System
(SINAN) and the records of suspected cases of dengue at the
University Hospital of the Federal University of Grande
Dourados during September 2009 and April 2010 in
Dourados, Mato Grosso do Sul. Indigenous patients and
patients whose records could not be located were excluded.
From the collected records, a survey of the following
epidemiological data was conducted: gender, age, and city
of residence. The clinical data obtained included reports of
fever, headache, myalgia, arthralgia, retro-orbital pain, skin
rash, vomiting, diarrhea, epistaxis, petechiae, gingival bleed-
ing, metrorrhagia, hematuria, warning signs, abdominal
pain, persistent vomiting, postural hypotension, hepatome-
galy, gastrointestinal hemorrhaging, drowsiness/irritability,
oliguria, hypothermia, respiratory distress, shock, hypoten-
sion, converging blood pressure, cold extremities, cyanosis,
rapid and thready pulse, slow capillary refill, and serous
effusions (pleural and peritoneal). The laboratory data
included a complete blood count (hematocrit, hemoglobin,
leukocyte count, and platelet count), liver enzymes (AST and
ALT), and liver function tests (albumin, PT, and aPTT). The
clinical outcomes included death, admission to the ICU, and
the need for blood transfusions (packed red blood cells,
plasma, and platelets). The clinical and laboratory data were
collected within the first 24 hours of admission.
Dengue patients were classified retrospectively based on
warning signs and disease severity. The warning signs were
as follows: abdominal pain or tenderness, persistent vomiting,
clinical fluid accumulation, mucosal bleeding, lethargy/rest-
lessness, liver enlargement greater than 2 cm, and an increase
in the hematocrit concurrent with a rapid decrease in platelet
count. The criteria used for SD were as follows: shock, fluid
accumulation with respiratory distress, severe bleeding, AST
or ALT greater than or equal to 1,000, impaired consciousness,
and severe involvement of the heart and other organs.
These data were tabulated and analyzed to evaluate the
primary variables associated with ICU admission and to
compare the traditional and revised WHO clinical classifica-
tions regarding the development and clinical severity of
disease. ICU admission was used as a proxy for disease
severity.
The variables were entered into the database of the Epi-
Data program, version 3.0, and analyzed using the SAS
statistical software, version 9.1.
The distribution pattern of each variable was evaluated,
and the statistical methods were selected based on the specific
distribution pattern. The variables that exhibited an asym-
metric distribution were evaluated using non-parametric
tests, whereas those that exhibited a normal distribution were
evaluated using parametric tests. Categorical or dichotomous
data were analyzed using the chi-square test or Fisher’s exact
test when the number of subjects per cell was less than 5.
The study was approved by the committee for ethics in
research of the Federal University of Grande Dourados
under number 01304112.9.0000.5160.
& RESULTS
Between September 2009 and April 2010, 7,827 dengue
cases were reported to the SINAN (3,913 cases per 100,000
inhabitants), and 495 (6.32%) patients were hospitalized. A
total of 211 patients were admitted to the University
Hospital of the Federal University of Grande Dourados.
Twenty-four cases were excluded: 22 patient records could
not be located, and 2 patients were indigenous people. The
study included 187 patients from SINAN who were
admitted to the University Hospital of the Federal
University of Grande Dourados. Of these, 77 (41.4%) were
male. The patients ranged in age from 1 to 90 years, with an
average age of 37.1 years. The majority of patients (90.8%)
lived in the city of Dourados (Table 1). During the epidemic,
not all cases were confirmed; 160/187 (86%) patients
underwent serological examination; 12% were negative,
57% were positive, and 31% were inconclusive for dengue.
The most common classical symptom of dengue was
fever, which was present in 173 patients (98.3%), followed
by myalgia (84.5%) and headache (78.1%). Warning signs
were present in 108 patients (60.7%). Of these warning
signs, the most frequent was abdominal pain, which was
present in 92 patients (53.5%). Nineteen patients (11.4%)
presented with signs of shock (Table 1).
Based on the traditional classification, the distribution of
the patients in the study was 82.9% DF, 14.9% DHF, and
2.2% DSS. The revised classification placed DWWS at 24.3%,
DWS at 59.1%, and SD at 15.6% (Figure 1).
Of the 150 patients classified as having DF, 105 (70%)
were reclassified as DWS or SD. None of the patients
classified as DHF or DSS were reclassified as DWWS
(Table 2). With the new classification, 96.2% of patients
admitted to the ICU were classified as DWS/SD. By the
traditional classification, 53.8% were classified as DHF/DSS
(p = 0.4615) (Table 3). With the new classification, 71.8% of
patients admitted to the ward were classified as DWS/SD,
whereas by the traditional classification, 11.4% were
classified as DHF/DSS (p = 0.0061) (Table 4). We found that
the majority of the classical signs and symptoms were not
associated with disease severity. Most of the warning signs
were associated with an indication for ICU admission and
were severe. The same results were observed for the
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variables associated with a specific outcome, such as death
or the need for a blood transfusion (Table 5).
& DISCUSSION
This study was conducted during a major dengue
epidemic in the state of Mato Grosso do Sul from
September 2009 to October 2010. During the first 13 weeks
of the epidemic in 2010, there were 59,199 reported cases of
dengue statewide (13.2% of the cases reported nationally).
Mato Grosso do Sul had the 4th highest number of cases of
any state in the country and the 2nd highest incidence
(2,507.8 cases per 100,000 inhabitants) (14).
The frequencies of the classical signs and symptoms,
hemorrhagic manifestations, and warning signs of dengue
fever observed in this study were similar to those of
Table 1 - The distribution of demographic, clinical, and laboratory data and the clinical outcomes of patients
hospitalized with suspected dengue at the University Hospital of the Federal University of Grande Dourados from
September 2009 to April 2010 (N=187).
Variable DF DHF and SSD p-value
Demographic data
Gender - Male, N (%) 63/150 (42.0%) 11/31 (35.5%) 0.5017
Age, mean +/- SD 37.8 +/- 22.1 33.4 +/- 27.6 0.5124a
Clinical data
Fever, N (%) 140/142 (98.6%) 30/30 (100%) 0.5132
Myalgia, N (%) 115/134 (85.8%) 19/24 (79.2%) 0.4029
Headache, N (%) 96/122 (78.7%) 20/26 (76.9%) 0.8426
Vomiting, N (%) 66/114 (57.9%) 19/25 (76.0%) 0.0926
Arthralgia, N (%) 51/97 (52.16%) 6/19 (31.6%) 0.0941
Skin rash, N (%) 44/92 (47.8%) 9/19 (47.4%) 0.9710
Retro-orbital pain, N (%) 42/95 (44.2%) 3/16 (18.8%) 0.0962b
Diarrhea, N (%) 34/98 (34.7%) 11/24 (45.8%) 0.3107
Hemorrhagic signs
Petechiae, N (%) 63/124 (50.8%) 17/31 (54.8%) 0.6878
Epistaxis, N (%) 21/116 (18.1%) 11/30 (36.7%) 0.0285
Gingival bleeding, N (%) 27/121 (22.3%) 6/29 (20.7%) 0.8496
Metrorrhagia, N (%) 15/114 (13.2%) 3/29 (10.3%) 1.0000b
Gastrointestinal hemorrhaging, N (%)
Hematuria, N (%) 7/113 (6.2%) 2/28 (7.1%) 1.0000b
Warning signs, N (%) 80/145 (55.2%) 28/31 (90.3%) 0.0003
Abdominal pain, N (%) 69/140 (49.3%) 23/30 (76.7%) 0.0063
Serous effusions, N (%) 14/136 (10.3%) 13/29 (44.8%) ,0.0001
Respiratory distress, N (%) 11/131 (8.4%) 9/26 (34.6%) 0.0002
Shock, N (%) 12/134 (9.0%) 7/31 (22.6%) 0.0322
Hypotension, N (%) 11/129 (8.5%) 6/30 (20.0%) 0.0670
Drowsiness/irritability, N (%) 6/131 (4.6%) 10/30 (33.3%) ,0.0001
Postural hypotension, N (%) 5/239 (3.9%) 4/36 (15.4%) 0.0438b
Persistent vomiting, N (%) 4/131 (3.1%) 3/29 (13.8%) 0.0366b
Hepatomegaly, N (%) 5/132 (3.8%) 3/29 (10.3%) 0.1562b
Hypothermia, N (%) 2/130 (1.5%) 4/30 (13.3%) 0.0954b
Cyanosis, N (%) 2/127 (1.6%) 3/30 (10.0%) 0.0484b
Oliguria, N (%) 2/130 (1.5%) 3/29 (10.3%) 0.0426b
Rapid and thready pulse, N (%) 2/127 (1.6%) 2/30 (6.7%) 0.1652b
Cold extremities, N (%) 1/127 (0.8%) 2/30 (6.7%) 0.0937b
Slow capillary refill, N (%) 1/127 (0.8%) 1/30 (3.3%) 0.3466b
Converging blood pressure, N (%) 0/127 (0%) 0/30
Laboratory data
Platelet count, mean +/- SD 81,9 +/- 87,0 43,8 +/- 62,6 0.0219a
Hematocrit, mean +/- SD 37.9 +/- 5.0 39.1 +/- 6.7 0.2600a
Hemoglobin, mean +/- SD 12.4 +/- 2.0 12.8 +/- 2.8 0.6041a
Leukocyte count, mean +/- SD 2,1 +/- 1,7 2,3 +/- 1,5 0.6409a
AST, mean +/- SD 99.1 +/- 63.9 1011.0 +/- 3226.7 0.0058a
ALT, mean +/- SD 70.5 +/- 5.6 431.8 +/- 178.7 0.0002a
Albumin, mean +/- SD 3.5 +/- 0.5 2.9 +/- 0.6 0.0010a
TP, mean +/- SD 14.6 +/- 2.3 18.6 +/- 8.5 0.0026a
aPTT, mean +/- SD 45.4 +/- 13.2 58.1 +/- 27.0 0.0254a
Clinical outcome
Death, N (%) 1/140 (0.7%) 2/28 (7.1%) 0.0724b
ICU admission, N (%) 12/144 (8.3%) 14/31 (45.2%) ,0.0001
Length of hospitalization (days), mean +/- SD 3.5 +/- 3.5 8.8 +/- 10.2 ,0.0001a
Length of hospitalization in ICU (days), mean +/- SD 5.5 +/- 9.3 10.2 +/- 12.4 0.3333a
Blood transfusion, N (%) 13/147 (8.8%) 11/29 (37.9%) ,0.0001
Packed red blood cells, N (%) 5/147 (3.4%) 6/29 (20.7%) 0.0004
Platelets, N (%) 8/147 (5.4%) 8/29 (27.6%) 0.0002
Plasma, N (%) 3/147 (2.0%) 4/29 (13.8%) 0.0149b
N (number of patients), SD (standard deviation), AST (aspartate aminotransferase), ALT (alanine aminotransferase), PT (prothrombin time), aPTT
(activated partial thromboplastin time), ICU (intensive care unit), a T-test, b Fisher Exact Test.
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previously published studies (15-17). Laboratory data, such
as platelet counts, were frequently recorded (73% of cases)
and were consistent with the frequencies reported by
Cortin˜as et al. (70.5%), Barniol et al. (72%), and Moura˜o
et al. (89.9%) (6,15,16).
Using the traditional 1997 WHO classification, the
majority of patients were classified as having dengue fever
(82.9%) (18). These data, although slightly higher, were
similar in pattern to those reported by Moura˜o et al. (66.3%),
Barniol et al. (67.1%), and Narvaez et al. (70.8%) (4,6,16). The
use of the traditional classification system as a criterion for
admission to the hospital was not useful. The majority of
patients admitted to the hospital were classified as DF.
Notably, 8.3% of the DF patients required ICU admission,
indicating that the traditional classification was unable to
identify the patients who developed more severe disease.
When the two classifications were compared, the majority
of the DF patients (70%) were reclassified as DWS or SD.
Similar data were reported in the studies by Barniol et al.
(57.6%) and Narvaez et al. (93.4%) (4,6). In the study by
Narvaez et al., 6.6% of patients were reclassified as having
dengue without warning signs (6).
The criteria for DHF were very rigid in the traditional
1997 WHO classifications. Patients could be classified as
DHF if they presented with all of the following signs (20):
fever for two to seven days, thrombocytopenia (#100,000/
mm3), hemorrhagic manifestations (positive tourniquet test,
hemorrhagic skin, and mucosal bleeding), and plasma
leakage due to increased capillary permeability (a 20%
increase in hematocrit values over the baseline at admission,
a 20% decrease in hematocrit values after the appropriate
treatment, and the presence of pleural effusion, ascites, or
hypoproteinemia).
The requirement of meeting all of the criteria caused
difficulty in detecting severe cases. Several authors reported
difficulties in determining the criteria and classifying
patients as DHF (4,19-21). In many situations, it is difficult
to demonstrate hemoconcentration based on a 20% increase
in hematocrit values; intravenous fluid replacement may
alter hematocrit levels and hamper the use of this criterion.
Many countries do not have a normal hematocrit value for
their population, making it difficult to determine the 20%
limit. Some researchers use hematocrit values to evaluate
hemoconcentration during convalescence. This evaluation
involves a retrospective diagnosis, which is not intended to
predict the risk of developing severe disease (6).
Another limitation was the need to perform laboratory
tests to diagnose DHF; these tests included hematocrit,
platelet count, serum albumin, chest radiography, and
abdominal ultrasound tests. The requirement for these tests
could complicate the diagnosis in countries in which access
to these tests is limited (22). These data demonstrate the low
Figure 1 - Distribution of patients with suspected dengue who were admitted to HU/UFGD from September 2009 to April 2010
according to the traditional and revised WHO classifications (N=187). DF (dengue fever), DHF (dengue hemorrhagic fever), DSS
(dengue shock syndrome), DWWS (dengue without warning signs), DWS (dengue with warning signs), SD (severe dengue).
Table 2 - Correlations between the traditional and revised
WHO classifications of patients with suspected dengue
who were hospitalized at the University Hospital of the
Federal University of Grande Dourados from September
2009 to April 2010.
DWWS DWS SD TOTAL p-value
DF 45 (30%) 90 (60%) 15 (10%) 150 ,0.0001
DHF 0 (0%) 17 (63%) 10 (37%) 27
DSS 0 (0%) 0 (0%) 4 (100%) 4
TOTAL 45 107 29 181
DF (dengue fever), DHF (dengue hemorrhagic fever), DSS (dengue shock
syndrome), DWWS (dengue without warning signs), DWS (dengue with
warning signs), SD (severe dengue).
Table 3 - Correlations between the traditional and revised
WHO classifications of patients with suspected dengue
who were admitted to the Intensive Care Unit at the
University Hospital of the Federal University of Grande
Dourados from September 2009 to April 2010.
DWWS DWS/SD TOTAL
DF 1 (8.3%) 11 (91.7%) 12 (46.2%)
DHF/DSS 0 (0%) 14 (100%) 14 (53.8%)
TOTAL 1 (8.3%) 25 (96.2%) 26 (100.0%)
DF (dengue fever), DHF (dengue hemorrhagic fever), DSS (dengue shock
syndrome), DWWS (dengue without warning signs), DWS (dengue with
warning signs), SD (severe dengue).
Classifications of dengue cases in Brazil
Lima FR et al.
CLINICS 2013;68(10):1299-1304
1302
discriminatory power of the traditional classification in
detecting severe cases of dengue. Previous studies have
demonstrated that the level of detecting severe cases of
dengue is 39% for the traditional classification and 92% for
the revised classification (6,23).
The increased discriminatory power of the revised
classification can be explained by the requirement for a
single criterion (warning sign) to classify a patient as being
at risk of progressing to severe disease (4). The presence of
shock, independent of thrombocytopenia or hemoconcen-
tration, is sufficient to classify a patient as having SD (4,23).
The classical signs and symptoms of dengue were not
significantly correlated with the need for ICU admission.
The majority of the warning signs that determine disease
severity (with the exception of uncontrollable vomiting,
hepatomegaly, and serous effusions) were strongly asso-
ciated with ICU admission. These warning signs were
significantly correlated with disease that resulted in death
or the need for a blood transfusion.
By using the ICU as a proxy for the severity of illness, we
demonstrated that the new classification is more sensitive
(96.2%) than the traditional classification, but there is a
significant loss of specificity (28.2%). Although patients
admitted to the ICU have a higher frequency of warning
signs, an indication for ICU admission should not be based
Table 4 - Correlations between the traditional and revised
WHO classifications of patients with suspected dengue
who were admitted to the general ward at the University
Hospital of the Federal University of Grande Dourados
from September 2009 to April 2010.
DWWS DWS/SD TOTAL
DF 42 (31.8%) 90 (68.2%) 132 (88.6%)
DHF/DSS 0 (0%) 17 (11.4%) 17 (11.4%)
TOTAL 42 (28.2%) 107 (71.8%) 149 (100.0%)
DF (dengue fever), DHF (dengue hemorrhagic fever), DSS (dengue shock
syndrome), DWWS (dengue without warning signs), DWS (dengue with
warning signs), SD (severe dengue).
Table 5 - Clinical outcomes of patients with suspected dengue who were hospitalized at HU/UFGD from September 2009





to the ICU p-value
Demographics
Gender - Male, N (%) 12/27 (44.4%) 92/104 (60.1%) 0.1281
Clinical data
Fever, N (%) 24/24 (100%) 143/146 (97.9%) 0.4786
Headache, N (%) 14/19 (73.7%) 99/127 (77.95%) 0.6782
Myalgia, N (%) 11/16 (68.7%) 120/140 (85.7%) 0.0797
Arthralgia, N (%) 3/10 (30.0%) 52/104 (50.0%) 0.3244a
Retro-orbital pain, N (%) 1/8 (11.1%) 46/102 (45.1%) 0.0760a
Skin rash, N (%) 5/13 (38.5%) 49/98 (49.0%) 0.4756
Vomiting, N (%) 15/18 (83.3%) 66/118 (55.9%) 0.0274
Diarrhea, N (%) 8/17 (47.1%) 36/103 (35.0%) 0.3372
Epistaxis, N (%) 4/21 (19.0%) 15/122 (20.5%) 0.8792
Petechiae, N (%) 10/23 (43.5%) 68/130 (52.3%) 0.4349
Gingival bleeding, N (%) (%) 3/23 (13.0%) 30/125 (24.0%) 0.2907a
Metrorrhagia, N (%) 1/16 (5.9%) 8/68 (11.8%) 0.4687a
Hematuria, N (%) 2/22 (9.1%) 7/117 (6.0%) 0.6339a
Warning Signs*, N (%) 24/26 (92.3%) 82/146 (56.1%) 0.0005
Abdominal pain, N (%) 17/23 (73.9%) 74/143 (51.7%) 0.0474
Uncontrollable vomiting, N (%) 2/19 (10.5%) 5/137 (3.5%) 0.2036a
Postural hypotension, N (%) 4/17 (23.5%) 5/135 (3.7%) 0.0097a
Hepatomegaly, N (%) 1/19 (5.3%) 2/138 (4.4%) 1.0000a
Gastrointestinal hemorrhaging, N (%) 10/22 (45.5%) 17/139 (12.2%) 0.0001
Drowsiness, N (%) 8/21 (38.1%) 8/137 (5.8%) ,0.0001
Oliguria, N (%) 2/19 (10.5%) 3/137 (2.2%) 0.1126a
Hypothermia, N (%) 5/20 (25.0%) 1/137 (0.7%) 0.0021a
Respiratory distress, N (%) 8/18 (44.4%) 12/136 (8.8%) ,0.0001
Shock, N (%) 8/23 (34.8%) 10/140 (7.1%) ,0.0001
Hypotension, N (%) 7/22 (31.8%) 9/135 (6.7%) 0.0003
Converging blood pressure, N (%) 0/21 (0%) 0/134 (0%)
Cold extremities, N (%) 3/21 (14.3%) 0/134 (0%) 0.0022a
Cyanosis, N (%) 3/21 (14.3%) 2/134 (1.5%) 0.0181a
Rapid and thready pulse, N (%) 4/21 (19.0%) 0/134 (0%) ,0.0001a
Slow capillary refill, N (%) 2/21 (9.5%) 00/134 (0%) 0.0176a
Serous effusion, N (%) 13/20 (65.0%) 19/47 (40.4%) 0.0674
Pleural effusion, N (%) 7/16 (43.7%) 7/32 (21.9%) 0.1160
Ascites, N (%) 8/18 (44.4%) 15/32 (46.9%) 0.8685
Clinical outcome
Death, N (%) 3/22 (13.6%) 0/148 (0%) 0.0019a
Blood transfusion, N (%) 15/23 (65.2%) 8/153 (5.23%) ,0.0001a
Blood transfusion - packed erythrocytes, N (%) 9/23 (39.1%) 2/153 (1.2%) ,0.0001a
Blood transfusion - platelets, N (%) 10/23 (43.5%) 6/153 (3.9%) ,0.0001
Blood transfusion - plasma, N (%) 6/23 (26.1%) 0/153 (0%) ,0.0001a
N (number of patients), ICU (intensive care unit), * At least one warning sign, a Fisher Exact Test.
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on the presence of warning signs alone. Further studies with
a larger sample size are necessary to assess the associated
variables that could predict disease severity and ICU
admission. Prospective studies involving outpatients should
be performed to identify whether the new classification is
important in indicating hospitalization in different settings.
This study has some limitations and potential confound-
ing factors that are inherent in a retrospective design based
on a secondary database. The results of this study are
limited by the absence of important variables that may not
be recorded in medical charts, including symptoms,
physical exams, laboratory findings, and the use of
intravenous rehydration. Another relevant limitation is
using ICU admission as a proxy for disease severity. ICU
admission may not represent all severe cases due to a lack of
beds in an ICU. A less common limitation is that ICU
admission could be related to the age or comorbidities of a
patient.
We conclude that the revised WHO classification is more
effective than the traditional classification for identifying
severe cases of dengue. The revised classification exhibits
greater practical applicability in developing countries such
as Brazil because it is less dependent on complementary
exams. The ability to appreciate and recognize the warning
signs of the revised classification is essential for clinicians to
identify patients at risk of developing severe disease and to
determine an appropriate course of action on a per-case
basis. Future research to evaluate the warning signs of
patient outcomes and the cost-effectiveness of the new
classification system is necessary to ascertain whether the
new classification system requires further modification or
whether elements of the two classification systems can be
combined.
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